This is the case of Dgat2, whose hepatic deficiency in a murine MASLD model has been shown to lower fat accumulation by reducing triglyceride synthesis and de novo lipogenesis [38,39]. This evidence concerns the gene DGAT2 and metabolic dysfunction-associated steatotic liver disease.